- Report
- August 2025
- 150 Pages
Global
From €4291EUR$4,850USD£3,677GBP
- Report
- September 2025
- 110 Pages
Global
From €3500EUR$4,237USD£3,104GBP
- Report
- October 2025
- 100 Pages
United States
From €5265EUR$5,950USD£4,511GBP
- Report
- August 2026
- 191 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2026
- 278 Pages
Global
From €5176EUR$5,850USD£4,436GBP
- Report
- August 2026
- 372 Pages
Global
From €5176EUR$5,850USD£4,436GBP
- Report
- July 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- March 2026
- 30 Pages
Global
From €2433EUR$2,750USD£2,085GBP
- Report
- April 2026
- 180 Pages
Global
From €4203EUR$4,750USD£3,602GBP
- Report
- May 2026
- 294 Pages
Global
From €2212EUR$2,500USD£1,896GBP
- Report
- March 2026
- 170 Pages
Global
From €4291EUR$4,850USD£3,677GBP
- Report
- February 2026
- 260 Pages
Global
From €3196EUR$3,613USD£2,739GBP
€3761EUR$4,250USD£3,222GBP
- Report
- May 2025
- 120 Pages
Global
From €5265EUR$5,950USD£4,511GBP
- Report
- January 2024
- 150 Pages
Global
From €5265EUR$5,950USD£4,511GBP
- Report
- August 2025
- 183 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2025
- 184 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2025
- 199 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- March 2024
- 200 Pages
Global
From €3672EUR$4,150USD£3,147GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more